Request Trial
new-frontier-old-west
4 November 2013Biotechnology

New frontiers: potential barriers to patenting induced totipotent stem cell technology

It has for some years been possible to create pluripotent stem cells (stem cells capable of differentiating into many, but not all, other cell types of the body) from fully differentiated adult cells (so called ‘induced pluripotent stem cells’ [iPS cells]).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Pfizer strikes $10.5 billion oncology deal with Chinese biotech
4 June 2026   The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.
Biotechnology
Gilead to pay up to $5bn for antibody-drug conjugates push
8 April 2026   The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments.
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026   On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering.


Editor's picks

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

Editor's picks

Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026

More features

Pfizer strikes $10.5 billion oncology deal with Chinese biotech
Heated LNP litigation puts Moderna and Acuitas in the spotlight
UPC dispute resolution forum opens with ceremony in Slovenia
Kirkland & Ellis adds leading barrister in London
European court backs AstraZeneca unit in blood cancer combo dispute
Boehringer Ingelheim adds ex-Teva executive to patent team
UPC judge: ‘Expectations of you as a woman are the challenge’
Healthcare leads sweeping AI partnership in Singapore